Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders by longitudeadmin | May 10, 2016 | Portfolio News
BAROnova Announces Appointment of David S. Thrower as President and Chief Executive Officer by longitudeadmin | May 4, 2016 | Portfolio News
Collegium Announces Positive Topline Results of Comparative Clinical Trial Evaluating the Effect of Crushing Xtampza™ ER Compared with OxyContin® by longitudeadmin | May 4, 2016 | Portfolio News
Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2016 Financial Results by longitudeadmin | May 4, 2016 | Portfolio News
Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update by longitudeadmin | May 3, 2016 | Portfolio News
